Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.

Blakely CM, Watkins TBK, Wu W, Gini B, Chabon JJ, McCoach CE, McGranahan N, Wilson GA, Birkbak NJ, Olivas VR, Rotow J, Maynard A, Wang V, Gubens MA, Banks KC, Lanman RB, Caulin AF, St John J, Cordero AR, Giannikopoulos P, Simmons AD, Mack PC, Gandara DR, Husain H, Doebele RC, Riess JW, Diehn M, Swanton C, Bivona TG.

Nat Genet. 2017 Dec;49(12):1693-1704. doi: 10.1038/ng.3990. Epub 2017 Nov 6.

2.

Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.

Abegglen LM, Caulin AF, Chan A, Lee K, Robinson R, Campbell MS, Kiso WK, Schmitt DL, Waddell PJ, Bhaskara S, Jensen ST, Maley CC, Schiffman JD.

JAMA. 2015 Nov 3;314(17):1850-60. doi: 10.1001/jama.2015.13134.

3.

Solutions to Peto's paradox revealed by mathematical modelling and cross-species cancer gene analysis.

Caulin AF, Graham TA, Wang LS, Maley CC.

Philos Trans R Soc Lond B Biol Sci. 2015 Jul 19;370(1673). pii: 20140222. doi: 10.1098/rstb.2014.0222.

4.

Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox.

Roche B, Hochberg ME, Caulin AF, Maley CC, Gatenby RA, Misse D, Thomas F.

BMC Cancer. 2012 Sep 3;12:387. doi: 10.1186/1471-2407-12-387.

5.

Peto's Paradox: evolution's prescription for cancer prevention.

Caulin AF, Maley CC.

Trends Ecol Evol. 2011 Apr;26(4):175-82. doi: 10.1016/j.tree.2011.01.002. Review.

Supplemental Content

Loading ...
Support Center